Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
56.92
+1.50 (2.71%)
Aug 12, 2026, 12:13 PM EDT - Market open
Ionis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -565.17 | -381.39 | -453.9 | -366.29 | -269.72 | -28.6 |
Depreciation & Amortization | 26.93 | 22.69 | 21.99 | 22.5 | 22.11 | 19.56 |
Stock-Based Compensation | 163.34 | 133.87 | 130.2 | 105.81 | 100.26 | 120.68 |
Other Adjustments | 23.95 | 7.45 | 10.15 | 7.73 | -134.59 | 32.98 |
Change in Receivables | -6.27 | 26.13 | 5.59 | -72.06 | 36.36 | 14.31 |
Changes in Inventories | -25.84 | -13.67 | -5.07 | -2.47 | 5.33 | -2.84 |
Changes in Accounts Payable | 23.53 | -15.36 | 15.99 | 8.12 | 1.09 | -6 |
Changes in Accrued Expenses | 3.73 | 46.62 | 1.89 | 18.55 | 10.37 | -26.92 |
Changes in Income Taxes Payable | 2.8 | 2.68 | -2.12 | -4.1 | 6.21 | -0.28 |
Changes in Unearned Revenue | -64.14 | -69.73 | -156.82 | 13.97 | -71.25 | -82.83 |
Changes in Other Operating Activities | -666.8 | -27.88 | -68.85 | -39.27 | 19.46 | -9.26 |
Operating Cash Flow | -496.43 | -268.58 | -500.95 | -307.51 | -274.37 | 30.8 |
Operating Cash Flow Growth | - | - | - | - | - | -14.19% |
Capital Expenditures | -64.41 | -51.44 | -45.28 | -23.81 | -15.72 | -11.96 |
Sale of Property, Plant & Equipment | - | - | - | - | 254.08 | - |
Purchases of Intangible Assets | -6.67 | -5.64 | -5.06 | -4.18 | -4.38 | -5.95 |
Purchases of Investments | -1,629 | -1,919 | -1,853 | -1,771 | -1,486 | -1,131 |
Proceeds from Sale of Investments | 1,932 | 1,698 | 1,769 | 1,585 | 989.15 | 1,344 |
Investing Cash Flow | 232.15 | -277.78 | -134.03 | -214.13 | -262.64 | 194.91 |
Long-Term Debt Issued | - | 770 | - | 1,075 | - | 632.5 |
Long-Term Debt Repaid | -0.18 | -267.82 | -44.67 | -488.1 | -10.95 | -318.93 |
Net Long-Term Debt Issued (Repaid) | -0.18 | 502.19 | -44.67 | 586.9 | -10.95 | 313.57 |
Issuance of Common Stock | 266.64 | 192.6 | 522.73 | 49.44 | 6.37 | 11.57 |
Repurchase of Common Stock | - | - | - | - | -50.69 | -16.73 |
Net Common Stock Issued (Repurchased) | 266.64 | 192.6 | 522.73 | 49.44 | -44.31 | -5.16 |
Other Financing Activities | - | -18.95 | - | 7.74 | -0.03 | -62.48 |
Financing Cash Flow | 317.36 | 675.84 | 478.06 | 644.08 | -55.3 | 245.93 |
Foreign Exchange Rate Adjustments | -0.31 | 0.7 | -0.27 | 0.35 | -0.42 | -0.11 |
Net Cash Flow | 52.76 | 130.18 | -157.19 | 122.79 | -592.72 | 471.53 |
Free Cash Flow | -560.84 | -320.03 | -546.23 | -331.32 | -290.09 | 18.84 |
Free Cash Flow Growth | - | - | - | - | - | 2340.93% |
FCF Margin | -64.16% | -33.91% | -77.46% | -42.06% | -49.39% | 2.33% |
Free Cash Flow Per Share | -3.44 | -2.00 | -3.65 | -2.31 | -2.05 | 0.13 |
Levered Free Cash Flow | -879.02 | 14.7 | -736.84 | 214.1 | -303.08 | 164.45 |
Unlevered Free Cash Flow | -868.18 | -489.57 | -706.98 | -394.47 | -451.26 | -150.14 |